- Home
- Applications
- north america
- real time pcr
Show results for
Refine by
Real Time Pcr Product Applications In North America
6 applications found
Premium
Whether nucleic acid extraction, protein analysis with ICP-MS or various PCR and qPCR/Real-time PCR solutions, early research, or the evaluation in clinical studies, our technologies and methods will increase efficiency of your entire ...
ByAnalytik Jena - an EndressHauser Company based in Jena, GERMANY
Due to the absence of fast, accurate, and timely methods of disease detection, millions of families are quarantined at home. ...
ByOnsiteGene Inc. based in San Diego, CALIFORNIA (USA)
What is Antimicrobial Resistance (AMR)? Antimicrobial resistance is the ability of microbes to resist the effects of drugs – that is, the germs are not killed, and their growth is not stopped. Although some people are at greater risk than others, no one can completely avoid the risk of antibiotic-resistant infections. Infections with resistant organisms are difficult to treat, requiring costly and sometimes toxic ...
ByOnsiteGene Inc. based in San Diego, CALIFORNIA (USA)
The rapid emergence of the COVID-19 pandemic has thrust tools like next generation sequencing (NGS) applications to the forefront of the global public health response. NGS is a sensitive and specific tool that is being used to detect the presence of the SARS-CoV-2 virus from a variety of clinical and environmental samples. Tracking SARS-CoV-2 viral strain evolution is critical for monitoring new regional outbreaks, contact tracing, infection control and verifying the performance of front-line RT-PCR diagnostic ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
Spartan’s test is a easy to use rapid solution that provides on-site high quality results within an ...
ByGenomadix based in Ottawa, ONTARIO (CANADA)
The antibody drug discovery process differs from the traditional drug discovery of small molecules as it requires the development of hybridomas and the engineering of antibodies to recognize a specific target protein. The production of recombinant antibodies in cancer treatment as well as the development of neutralizing antibodies for infectious diseases, has allowed antibody discovery platforms to interrogate the immune repertoire and develop novel antibody libraries using flow cytometry analysis and cell ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)